Dermatology News

Dermatology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Patel RV et al. - Many of the therapies for moderate to severe psoriasis, including PUVA, traditional systemic therapies, and some biologic therapies, may increase the risk of malignancy. Appropriate patient counseling and selection, as well as clinical follow-up, are necessary to maximize safety with these agents.


Today in Dermatologic Oncology...keeping you current

A practical approach to using methotrexate
Dermatology in Practice, 10/09/09

Positron emission tomography in early detection of relapse in high-risk melanoma patients: a retrospective review
Community Oncology , 10/09/09

Surgical excision margins for primary cutaneous melanoma
Cochrane Reviews, 10/09/09

Today in Psoriasis...keeping you current

A practical approach to using methotrexate
Dermatology in Practice, 10/09/09

Pediatric psoriasis: an update
Therapeutics and Clinical Risk Management, 10/22/09

Ustekinumab for the treatment of plaque psoriasis
Expert Review of Dermatology, 10/13/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address